← Leaderboards
Thomas C Hamilton
Fox Chase Cancer Center
$7,664,005
Attributed
$9,244,968
Total exposure
8
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $707.9K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$9,244,968 · 8
By mechanism
R01$3,561,205 · 3
P50$3,161,575 · 3
U01$2,512,188 · 1
R13$10,000 · 1
Top collaborators
- Peter J O'Dwyer5 shared
- Lin Zhang5 shared
Others in their field
Top investigators on “Ovary Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$212,807,834
- Philip J Disaia · University Of California Irvine$127,836,851
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$32,228,202
- Larry Arthur$28,462,007
- Joellen M. Schildkraut · Duke University$27,683,438
- Robert C Bast · University Of Texas Md Anderson Can Ctr$24,816,706
Research focus
Ovary NeoplasmsTumor Suppressor GenesNeoplasm /Cancer GeneticsHuman TissueOncogenesTissue /Cell CultureCell LineGene ExpressionPhenotypeMessenger RnaTumor Suppressor ProteinsAntisense Nucleic AcidPolymerase Chain ReactionNeoplastic CellResponseMalignant NeoplasmsComplementary DnaIn VitroEpitheliumBaseIn VivoMalignant Neoplasm Of OvaryApoptosisDisease /Disorder Model
Grant awards (30)
Therapeutic Micro RNA Strategies for Ovarian Cancer$502,616
P50 · FY2013 · CA · contact PI
Therapeutic Micro RNA Strategies for Ovarian Cancer$426,838
P50 · FY2012 · CA · contact PI
Therapeutic Micro RNA Strategies for Ovarian Cancer$496,164
P50 · FY2011 · CA · contact PI
Therapeutic Micro RNA Strategies for Ovarian Cancer$522,716
P50 · FY2010 · CA · contact PI
Therapeutic Micro RNA Strategies for Ovarian Cancer$423,111
P50 · FY2009 · CA · contact PI
Loss of Vitamin A Metabolism in Ovarian Oncogenesis$284,831
R01 · FY2009 · CA · contact PI
Loss of Vitamin A Metabolism in Ovarian Oncogenesis$284,831
R01 · FY2008 · CA · contact PI
Loss of Vitamin A Metabolism in Ovarian Oncogenesis$284,831
R01 · FY2007 · CA · contact PI
Loss of Vitamin A Metabolism in Ovarian Oncogenesis$293,338
R01 · FY2006 · CA · contact PI
Loss of Vitamin A Metabolism in Ovarian Oncogenesis$300,546
R01 · FY2005 · CA
HHMT 10th Biennial International Forum on Ovarian Cancer$10,000
R13 · FY2005 · CA
MOUSE MODELS OF OVARIAN CANCER$663,283
U01 · FY2003 · CA
MOLECULAR GENETICS OF OVARIAN SURFACE NEOPLASIA$309,421
R01 · FY2003 · CA
MOUSE MODELS OF OVARIAN CANCER$646,801
U01 · FY2002 · CA
DNA REPAIR AND DRUG RESISTANCE IN OVARIAN CANCER$309,782
R01 · FY2002 · CA
MOLECULAR GENETICS OF OVARIAN SURFACE NEOPLASIA$303,343
R01 · FY2002 · CA
Career development program$165,355
P50 · FY2002 · CA
Determination of molecular pathways regulating LOT1 mediated growth suppressions$165,355
P50 · FY2002 · CA
MOUSE MODELS OF OVARIAN CANCER$609,598
U01 · FY2001 · CA
DNA REPAIR AND DRUG RESISTANCE IN OVARIAN CANCER$303,533
R01 · FY2001 · CA
MOLECULAR GENETICS OF OVARIAN SURFACE NEOPLASIA$299,207
R01 · FY2001 · CA
Determination of molecular pathways regulating LOT1 mediated growth suppressions$165,355
P50 · FY2001 · CA
Career development program$165,355
P50 · FY2001 · CA
MOUSE MODELS OF OVARIAN CANCER$592,506
U01 · FY2000 · CA
DNA REPAIR AND DRUG RESISTANCE IN OVARIAN CANCER$297,465
R01 · FY2000 · CA
MOLECULAR GENETICS OF OVARIAN SURFACE NEOPLASIA$290,077
R01 · FY2000 · CA
Determination of molecular pathways regulating LOT1 mediated growth suppressions$54,263
P50 · FY2000 · CA
Determination of molecular pathways regulating LOT1 mediated growth suppressions$54,263
P50 · FY2000 · CA
Career development program$10,092
P50 · FY2000 · CA
Career development program$10,092
P50 · FY2000 · CA